Vimta Labs Ltd (VIMTALABS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524394 | NSE: VIMTALABS | Business Support | Small Cap

Vimta Labs Share Price

598.30 -10.30 -1.69%
as on 05-Dec'25 14:23

Vimta Labs Ltd (VIMTALABS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524394 | NSE: VIMTALABS | Business Support | Small Cap

DeciZen - make an informed investing decision on Vimta Labs

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Vimta Labs stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
36.62
Market Cap:
2,716.5 Cr.
52-wk low:
372.5
52-wk high:
902.9

Is Vimta Labs Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Vimta Labs: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vimta Labs Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 7%11.2%16.6%20.4%6%14.2%23.9%24.3%20.6%25.2%-
Value Creation
Index
-0.5-0.20.20.5-0.60.00.70.70.50.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 125154183213181209276315289344382
Sales YoY Gr.-23.4%19.2%15.9%-15%15.7%32%14.2%-8.4%19.2%-
Adj EPS 1.42.53.85.61.34.99.510.510.914.916.6
YoY Gr.-71.5%52.2%49.7%-76.7%272.5%94.7%10.4%3.8%36.9%-
BVPS (₹) 28.530.834.438.839.143.952.26269.383.793.3
Adj Net
Profit
6.410.916.624.95.821.64246.548.366.374
Cash Flow from Ops. -123.933.439.324.43758.786.560.994.6-
Debt/CF from Ops. -25.61.81.20.71.30.80.30.20.30.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.9%13.7%7.6%19.2%
Adj EPS 29.7%62.7%16.2%36.9%
BVPS12.7%16.4%17.1%20.7%
Share Price 27.8% 49.5% 40.2% 30.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
5.18.311.515.43.411.719.618.116.219.118.8
Op. Profit
Mgn %
15.218.124.827.216.625.42929.732.635.534.9
Net Profit
Mgn %
5.17.19.111.73.210.315.214.716.719.319.4
Debt to
Equity
0.20.30.30.20.20.20.10.10.100
Working Cap
Days
19918716815819518615814816915792
Cash Conv.
Cycle
1189992101128113959211511462

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Vimta Labs Ltd.

Standalone Consolidated
TTM EPS (₹) 16.6 13.8
TTM Sales (₹ Cr.) 382 336
BVPS (₹.) 93.3 81.7
Reserves (₹ Cr.) 407 356
P/BV 6.52 7.45
PE 36.62 44.26
From the Market
52 Week Low / High (₹) 372.50 / 902.85
All Time Low / High (₹) 0.10 / 902.85
Market Cap (₹ Cr.) 2,717
Equity (₹ Cr.) 8.9
Face Value (₹) 2
Industry PE 38.7

Management X-Ray of Vimta Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vimta Labs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Vimta Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales125154183213181209276315289344
Operating Expenses 106127138155151156196222195222
Manufacturing Costs53595968636890877186
Material Costs002-1030000
Employee Cost 33434955585771868591
Other Costs 19242833292836493845
Operating Profit 192745583053809494122
Operating Profit Margin (%) 15.1%17.8%24.7%27.1%16.6%25.2%28.9%29.7%32.6%35.5%
Other Income 1112311344
Interest 1255421322
Depreciation 10101620212323313335
Exceptional Items 000000-1000
Profit Before Tax 817263582855646389
Tax 269101714171422
Profit After Tax 611162572141474967
PAT Margin (%) 5.2%6.9%9.0%11.9%3.8%10.2%14.9%15.0%16.9%19.4%
Adjusted EPS (₹)1.52.43.75.71.64.89.310.711.015.0
Dividend Payout Ratio (%)34%0%27%17%0%21%11%9%9%7%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 126136152172173194231274307372
Share Capital 4444444444
Reserves 122132148167169190226270303368
Minority Interest0000000000
Debt2637331722221310143
Long Term Debt16181912514131093
Short Term Debt10191351880050
Trade Payables615131110151214810
Others Liabilities 18333538394149585775
Total Liabilities 176222232237244272304356387460

Fixed Assets

Gross Block23198166180197216266300331427
Accumulated Depreciation1431025456688105133166197
Net Fixed Assets 8888140135131128162168166230
CWIP 653042170125938
Investments 0000666600
Inventories16151819171517232525
Trade Receivables384256595873778087106
Cash Equivalents 31337711392633
Others Assets 25221518242630282528
Total Assets 176222232237244272304356387460

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1243339243759876195
PBT 817263582855645490
Adjustment 11122330232931393734
Changes in Working Capital -191-9-16-1-13-11-4-15-8
Tax Paid -2-5-6-10-6-7-17-12-15-22
Cash Flow From Investing Activity -16-39-24-16-20-32-38-57-76-76
Capex -16-40-24-16-14-32-39-50-74-77
Net Investments 0-00-0-01-0-9-3-5
Others 0011-601126
Cash Flow From Financing Activity 1913-8-23-1-5-16-11-2-17
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 1682-7-67-3-5-1-6
Interest Paid -1-2-4-3-2-2-1-1-1-1
Dividend Paid -2-30-5-50-4-4-4-4
Others 69-6-812-9-8-05-5
Net Cash Flow 2-21131519-172

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)5.188.0811.415.644.0211.5819.3218.7316.7819.65
ROCE (%)6.9511.2216.5520.426.0114.2423.8524.2520.5525.23
Asset Turnover Ratio0.770.770.810.910.750.810.960.950.780.81
PAT to CFO Conversion(x)-0.172.182.061.563.431.761.441.851.241.42
Working Capital Days
Receivable Days939598981171149991106103
Inventory Days46373332372821233026
Payable Days002,187-5,63101,5170000

Vimta Labs Ltd Stock News

Vimta Labs Ltd FAQs

The current trading price of Vimta Labs on 05-Dec-2025 14:23 is ₹598.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Vimta Labs stood at ₹2,716.5.
The latest P/E ratio of Vimta Labs as of 04-Dec-2025 is 36.62.
The latest P/B ratio of Vimta Labs as of 04-Dec-2025 is 6.52.
The 52-week high of Vimta Labs is ₹902.9 and the 52-week low is ₹372.5.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vimta Labs is ₹382.4 ( Cr.) .

About Vimta Labs Ltd

Vimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies.

Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years.

Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated.

Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies.

Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area.

It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models.

Services offered by the company:

  • Advanced Molecular Biology
  • Food and Agriculture
  • Drugs & Pharma
  • Water
  • Environmental Assessments
  • Clinical Research
  • Clinical Reference Lab Services
  • Preclinical Research
  • Genomics Online Ordering

 Achievements/ recognition

  •    NABL as per ISO 15189:2007
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×